Cva Family Office, LLC Astrazeneca PLC Transaction History

Cva Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$61.03 - $69.57 $12,938 - $14,748	-212 Reduced 17.39%	1,007 $68,000
Q4 2023 Jan 16, 2024	BUY	$61.89 - $69.28 $75,443 - $84,452	1,219 New	1,219 $82,000
Q1 2023 Apr 26, 2023	SELL	$63.15 - $71.6 $10,798 - $12,243	-171 Reduced 12.3%	1,219 $84,000
Q4 2022 Feb 21, 2023	BUY	$54.21 - $70.44 $9,269 - $12,045	171 Added 14.03%	1,390 $94,000
Q4 2021 Jan 25, 2022	BUY	$54.02 - $63.83 $65,850 - $77,808	1,219 New	1,219 $71,000
Q3 2021 Oct 12, 2021	SELL	$55.56 - $60.79 $55,948 - $61,215	-1,007 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$48.42 - $60.18 $48,758 - $60,601	1,007 New	1,007 $60,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.